Karina Herrera Schoene: The CAR-T Cell Immersion at the University of Miami
Karina Herrera Schoene, Senior Hematology Product Manager at The Janssen Pharmaceutical Companies of Johnson & Johnson, shared a post on LinkedIn:
“Participating in the CAR-T Cell Immersion at the University of Miami a couple of days ago was an incredible experience.
It was an honor to observe the remarkable work of Dr. C. Ola Landgren, and his team. His dedication to advancing cellular therapies is truly inspiring.
I’m grateful for the valuable insights gained during this observership, which will certainly enrich my professional path.”
C. Ola Landgren, Leader, Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center, reshared the post on LinkedIn, adding:
“Thank you to our Brazilian myeloma expert colleagues for spending 2 days with our team at Sylvester Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami!
Lots of great clinical and scientific discussions, and sharing of experiences and new ideas. It was a true collaborative observership. We all learned a lot and we built many new collaborative bridges for the future.
Sylvester Myeloma Institute will continue developing our educational program and offer 2 day Observerships to international colleagues with interest in myeloma and novel treatment and management strategies.”
More posts featuring University of Miami.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023